This includes a review on the regulation of the oxidative capacity of muscle by PPAR-δ, opportunities for the development of PPAR-δ agonists for the treatment of obesity, and finally the effect of PPAR-δ activation on vascular pathophysiological processes. The gene discussed is PPARD; the disease is obesity due to melanocortin 4 receptor deficiency.